Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.

[1]  Cassandra Willyard.  The drug-resistant bacteria that pose the greatest health threats , 2017, Nature.

[2]  Rahul S. Kalhapure,et al.  Pegylated oleic acid: A promising amphiphilic polymer for nano‐antibiotic delivery , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  E. Gillies,et al.  Phosphonium-Functionalized Polymer Micelles with Intrinsic Antibacterial Activity. , 2017, Biomacromolecules.

[4]  A. Domb,et al.  Biodegradable Fatty Acid Polyesters , 2016 .

[5]  Rahul S. Kalhapure,et al.  Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies. , 2016, International journal of pharmaceutics.

[6]  Aijing Lu,et al.  The anti-bacterial poly(caprolactone)-poly(quaternary ammonium salt) as drug delivery carriers , 2016, Applied Microbiology and Biotechnology.

[7]  O. Bamgbola.  Review of vancomycin-induced renal toxicity: an update , 2016, Therapeutic advances in endocrinology and metabolism.

[8]  M. Balouiri,et al.  Methods for in vitro evaluating antimicrobial activity: A review☆ , 2015, Journal of pharmaceutical analysis.

[9]  Rahul S. Kalhapure,et al.  Solid lipid nanoparticles of clotrimazole silver complex: An efficient nano antibacterial against Staphylococcus aureus and MRSA. , 2015, Colloids and surfaces. B, Biointerfaces.

[10]  B. Gilmore,et al.  The antimicrobial potential of ionic liquids: A source of chemical diversity for infection and biofilm control. , 2015, International journal of antimicrobial agents.

[11]  M. Jennings,et al.  Quaternary Ammonium Compounds: An Antimicrobial Mainstay and Platform for Innovation to Address Bacterial Resistance. , 2015, ACS infectious diseases.

[12]  Thirumala Govender,et al.  Nanoengineered drug delivery systems for enhancing antibiotic therapy. , 2015, Journal of pharmaceutical sciences.

[13]  Rahul S. Kalhapure,et al.  Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. , 2014, Colloids and surfaces. B, Biointerfaces.

[14]  P. Caliceti,et al.  Novel pH-responsive nanovectors for controlled release of ionisable drugs. , 2013, Journal of materials chemistry. B.

[15]  D. Kamei,et al.  Mathematical Modeling of Vesicle Drug Delivery Systems 1 , 2013, Journal of laboratory automation.

[16]  J. Feijen,et al.  Polymersomes for drug delivery: design, formation and characterization. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[17]  T. Lu,et al.  Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. , 2012, ACS nano.

[18]  P. Das,et al.  Pyridinium based amphiphilic hydrogelators as potential antibacterial agents , 2010, Beilstein journal of organic chemistry.

[19]  Chong Cheng,et al.  Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities , 2010, Journal of materials science. Materials in medicine.

[20]  R. Pignatello,et al.  Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. , 2010, International journal of antimicrobial agents.

[21]  Prasanta Chowdhury,et al.  Kinetic modeling on drug release from controlled drug delivery systems. , 2010, Acta poloniae pharmaceutica.

[22]  P. Das,et al.  Hydrogelation through self-assembly of fmoc-peptide functionalized cationic amphiphiles: potent antibacterial agent. , 2010, The journal of physical chemistry. B.

[23]  Rachel K. O'Reilly,et al.  Advances and challenges in smart and functional polymer vesicles , 2009 .

[24]  E. Smith,et al.  Experimental design for the optimization of lipid nanoparticles. , 2009, Journal of pharmaceutical sciences.

[25]  G. Tew,et al.  Antibacterial and Hemolytic Activities of Quaternary Pyridinium Functionalized Polynorbornenes , 2008 .

[26]  Chi-Hwa Wang,et al.  Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. , 2006, Advanced drug delivery reviews.

[27]  Mariana S. Costa,et al.  Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. , 2006, International journal of pharmaceutics.

[28]  P. Kondaiah,et al.  Synthesis and antibacterial properties of novel hydrolyzable cationic amphiphiles. Incorporation of multiple head groups leads to impressive antibacterial activity. , 2005, Journal of medicinal chemistry.

[29]  Charles F. Kulpa,et al.  Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids , 2005 .

[30]  Jianzhong Du,et al.  Organic-inorganic hybrid nanoparticles with a complex hollow structure. , 2004, Angewandte Chemie.

[31]  A. Balaban,et al.  Pyridinium cationic lipids in gene delivery: a structure-activity correlation study. , 2004, Journal of medicinal chemistry.

[32]  M. Hashida,et al.  In vitro cytotoxicity of macromolecules in different cell culture systems , 1995 .

[33]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[34]  J. Swarbrick,et al.  Interaction of quaternary ammonium bactericides with biological materials. I. Conductometric studies with cephalin. , 1972, Journal of pharmaceutical sciences.

[35]  Chun-Ming Huang,et al.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.

[36]  EuropeanCommittee forAntimicrobial SusceptibilityTesting.  EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.